While the anti-IgE biologic omalizumab has been traditionally prescribed for allergic asthma, it is currently also indicated as an add-on therapy with intranasal corticosteroids for the treatment of severe CRSwNP. The gene discussed is IGHE; the disease is chronic rhinosinusitis with nasal polyps.